NAD+ (Nicotinamide Adenine Dinucleotide) is the central coenzyme of cellular energy metabolism, and its decline with age is a primary driver of the fatigue, cognitive decline, and metabolic dysfunction that many women experience in their 40s and beyond. For women navigating perimenopause, menopause, or the demands of high-stress careers and family responsibilities, NAD+ restoration offers a foundational intervention for cellular health.
Estrogen, NAD+, and Mitochondrial Health
Estrogen has direct effects on mitochondrial function and NAD+ metabolism. Estrogen receptor beta (ERβ), which is highly expressed in mitochondria, regulates the expression of enzymes involved in NAD+ synthesis. As estrogen declines during perimenopause, NAD+ levels fall more rapidly — contributing to the fatigue, brain fog, and metabolic slowdown that characterize this transition.
SIRT1 and Hormonal Regulation
NAD+ is the essential substrate for SIRT1, a deacetylase enzyme that regulates hundreds of genes involved in metabolism, inflammation, and stress response. SIRT1 also directly interacts with estrogen receptor alpha (ERα), modulating its activity. Restoring NAD+ levels may therefore have downstream effects on hormonal signaling that extend beyond simple energy production.
Cognitive Health and Brain Fog
Brain fog — characterized by difficulty concentrating, memory lapses, and mental fatigue — is one of the most commonly reported and least discussed symptoms of perimenopause. NAD+ supports neuronal energy production and activates SIRT3 in brain mitochondria, which is associated with improved cognitive function and neuroprotection.